RELX Reaffirms Strong Outlook Despite Share Price Dip

RELX Confirms Positive Full-Year Projections

RELX has reaffirmed its full-year outlook, projecting strong underlying growth in both revenue and adjusted operating profit. The company also anticipates robust growth in adjusted earnings per share on a constant currency basis, despite a 2.8% drop in its Amsterdam-listed shares following the announcement.

Broad-Based Growth Across Business Segments

The company reported strong performance and new sales across its key divisions. The Scientific, Technical & Medical (STM) division saw a significant increase in article submissions. Meanwhile, the Legal division continued its momentum with double-digit growth in its Law Firms & Corporate Legal segments.

Market Reaction and Divisional Resilience

Despite the confident forecast, RELX shares listed in Amsterdam declined by 2.8% in early trading. The company's Exhibitions division maintains a strong growth outlook and expects an improved operating margin. This projection holds firm even with some event rescheduling in the Middle East, demonstrating resilience against regional conflicts. The outlook for the Risk, STM, and Legal segments remains unchanged.

Outlook Summary

RELX's management remains confident in its financial targets for the year, supported by consistent growth across its diverse portfolio. The market will be watching to see if the share price aligns with the company's positive operational performance in the coming months.

FAQ

Q: What is RELX's full-year financial outlook?
A: The company expects strong underlying growth in revenue, adjusted operating profit, and adjusted earnings per share.

Q: How did RELX's stock react to the announcement?
A: Its Amsterdam-listed shares fell by 2.8% in morning trading on Thursday.

Q: Were any business divisions impacted by external events?
A: The Exhibitions division rescheduled some events due to the Middle East conflict, but its overall strong growth outlook remains unchanged.

Source: Investing.com